Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol dosage in aneurysmal subarachnoid hemorrhage craniotomy
NCT04135456Phase 2Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2019
- Primary completion
- Nov 2023
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Bronchitol in aneurysmal subarachnoid hemorrhage (SAH) (3 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Brain relaxation score. Status: unknown.
02
Drugs
Bronchitol
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04135456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135456.